really good argument and in this day and age, "porque no los dos?", why can't we have both ?
Triangle discounted the cardio protect value by 50%, so why can't we have one BP paying 50% upfront, USD5-8B, and the remaining 50%, $5-8B, paid out in royalties on a sliding scale, ie. majority paid out in bisantrene's patent life and less when generics come into play?
same goes for FTO and $1B AML
certainly a lot more digestible...
AbbVie paid USD22B for only 50% of Pharmacyclics and the other 50% was owned by J&J, instos and SHs who enjoyed royalties/divies of some sort
- Forums
- ASX - By Stock
- Ann: Race releases complete cardio-protection data & video
really good argument and in this day and age, "porque no los...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.82 |
Change
0.105(6.14%) |
Mkt cap ! $309.0M |
Open | High | Low | Value | Volume |
$1.85 | $1.96 | $1.75 | $862.1K | 467.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.82 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.810 |
1 | 95 | 1.800 |
1 | 14586 | 1.785 |
3 | 3732 | 1.780 |
1 | 500 | 1.775 |
Price($) | Vol. | No. |
---|---|---|
1.820 | 5000 | 1 |
1.825 | 1293 | 1 |
1.830 | 3143 | 3 |
1.835 | 226 | 1 |
1.850 | 4600 | 2 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |